← Devices & Neurotechnology
Details checkedClinical trial listing onlyCheckedregistry
Nantong newborn deafness-gene screening cohort
Also known as: Genetic screening test, Deafness gene variant detection array kit, Cohort of universal newborn deafness-gene screening
Institution-led study
Sponsor / Institution
Institution-led study
Program Type
Diagnostic
Modality
Genetic Screening Test
Stage
Not applicable
Status
Active
Target Gene
—
Route / Mode
Genetic screening test
Confidence
88%
Status Confidence
Status needs checking
Evidence Strength
Needs more support
Last Reviewed
2026-06-10
Geography
China
Population
newborn, pediatric, genetic, screening
Trial IDs
1
Mechanism
Prospective newborn cohort using combined hearing screening and a deafness-gene variant detection array for variants in GJB2, SLC26A4, MT-RNR1, and GJB3.
Indications
Notes
Registry-verified active newborn deafness-gene screening cohort. It is a diagnostic screening study, not therapeutic gene therapy.
Evidence & Sources
1 structured sourcesclinicaltrials
Supports: canonicalName, company, allCompanies, isIndustrySponsored, programType, modality, mechanism, indications...
IDs: NCT06133946
Key Events
Clinical Trials (1)
Data Checks
institution-led-studyregistry-only-evidencegenetic-testing-not-gene-therapydiagnostic-screening-studywas-therapeutic-misclassification
Related Programs
Apple AirPods Pro Hearing Health Features
Company: Apple · Hearing Aid/Software · Marketed
Nuance Audio Hearing Aid Software
Company: EssilorLuxottica · Hearing Aid/Software · Marketed
Cochlear Nucleus Nexa System
Company: Cochlear · Cochlear/Auditory Implant · Marketed
Envoy Medical Acclaim Cochlear Implant
Company: Envoy Medical · Cochlear/Auditory Implant · Phase 2/3
MED-EL SYNCHRONY Cochlear Implant System
Company: MED-EL · Cochlear/Auditory Implant · Marketed
Phonak Audéo Sphere Infinio
Company: Phonak · Hearing Aid/Software · Marketed